These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16939848)

  • 1. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.
    Argyriou AA; Chroni E; Koutras A; Iconomou G; Papapetropoulos S; Polychronopoulos P; Kalofonos HP
    J Pain Symptom Manage; 2006 Sep; 32(3):237-44. PubMed ID: 16939848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.
    Argyriou AA; Chroni E; Koutras A; Ellul J; Papapetropoulos S; Katsoulas G; Iconomou G; Kalofonos HP
    Neurology; 2005 Jan; 64(1):26-31. PubMed ID: 15642899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results.
    Argyriou AA; Chroni E; Koutras A; Iconomou G; Papapetropoulos S; Polychronopoulos P; Kalofonos HP
    Support Care Cancer; 2006 Nov; 14(11):1134-40. PubMed ID: 16622646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel.
    Loven D; Levavi H; Sabach G; Zart R; Andras M; Fishman A; Karmon Y; Levi T; Dabby R; Gadoth N
    Eur J Cancer Care (Engl); 2009 Jan; 18(1):78-83. PubMed ID: 19473225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy.
    Argyriou AA; Chroni E; Polychronopoulos P; Iconomou G; Koutras A; Makatsoris T; Gerolymos MK; Gourzis P; Assimakopoulos K; Kalofonos HP
    Neurology; 2006 Dec; 67(12):2253-5. PubMed ID: 17190958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on the relation between cisplatin neuropathy and vitamin E.
    Bove L; Picardo M; Maresca V; Jandolo B; Pace A
    J Exp Clin Cancer Res; 2001 Jun; 20(2):277-80. PubMed ID: 11484987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial.
    Pace A; Giannarelli D; Galiè E; Savarese A; Carpano S; Della Giulia M; Pozzi A; Silvani A; Gaviani P; Scaioli V; Jandolo B; Bove L; Cognetti F
    Neurology; 2010 Mar; 74(9):762-6. PubMed ID: 20194916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
    Vahdat L; Papadopoulos K; Lange D; Leuin S; Kaufman E; Donovan D; Frederick D; Bagiella E; Tiersten A; Nichols G; Garrett T; Savage D; Antman K; Hesdorffer CS; Balmaceda C
    Clin Cancer Res; 2001 May; 7(5):1192-7. PubMed ID: 11350883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy.
    Argyriou AA; Polychronopoulos P; Koutras A; Xiros N; Petsas T; Argyriou K; Kalofonos HP; Chroni E
    Eur J Cancer Care (Engl); 2007 May; 16(3):231-7. PubMed ID: 17508942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.
    Ghoreishi Z; Esfahani A; Djazayeri A; Djalali M; Golestan B; Ayromlou H; Hashemzade S; Asghari Jafarabadi M; Montazeri V; Keshavarz SA; Darabi M
    BMC Cancer; 2012 Aug; 12():355. PubMed ID: 22894640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of vitamin E on chemotherapy-induced peripheral neuropathy: a meta-analysis of randomized controlled trials.
    Eum S; Choi HD; Chang MJ; Choi HC; Ko YJ; Ahn JS; Shin WG; Lee JY
    Int J Vitam Nutr Res; 2013; 83(2):101-11. PubMed ID: 24491883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
    Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study.
    Weijl NI; Elsendoorn TJ; Lentjes EG; Hopman GD; Wipkink-Bakker A; Zwinderman AH; Cleton FJ; Osanto S
    Eur J Cancer; 2004 Jul; 40(11):1713-23. PubMed ID: 15251161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population.
    Plummer M; Vivas J; Lopez G; Bravo JC; Peraza S; Carillo E; Cano E; Castro D; Andrade O; Sánchez V; Garcia R; Buiatti E; Aebischer C; Franceschi S; Oliver W; Muñoz N
    J Natl Cancer Inst; 2007 Jan; 99(2):137-46. PubMed ID: 17227997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer.
    Mielke S; Sparreboom A; Steinberg SM; Gelderblom H; Unger C; Behringer D; Mross K
    Clin Cancer Res; 2005 Jul; 11(13):4843-50. PubMed ID: 16000582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of vitamin E supplementation and cognitive function in women.
    Kang JH; Cook N; Manson J; Buring JE; Grodstein F
    Arch Intern Med; 2006 Dec 11-25; 166(22):2462-8. PubMed ID: 17159011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel/platinum-based chemotherapy: final results of the After-6 protocol 1.
    Pecorelli S; Favalli G; Gadducci A; Katsaros D; Panici PB; Carpi A; Scambia G; Ballardini M; Nanni O; Conte P;
    J Clin Oncol; 2009 Oct; 27(28):4642-8. PubMed ID: 19704064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
    Rizvi NA; Riely GJ; Azzoli CG; Miller VA; Ng KK; Fiore J; Chia G; Brower M; Heelan R; Hawkins MJ; Kris MG
    J Clin Oncol; 2008 Feb; 26(4):639-43. PubMed ID: 18235124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.